291 related articles for article (PubMed ID: 34491250)
1. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
Front Immunol; 2021; 12():716361. PubMed ID: 34491250
[TBL] [Abstract][Full Text] [Related]
2. C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19.
Adesanya TMA; Campbell CM; Cheng L; Ogbogu PU; Kahwash R
J Clin Immunol; 2021 May; 41(4):729-732. PubMed ID: 33474624
[No Abstract] [Full Text] [Related]
3. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
[TBL] [Abstract][Full Text] [Related]
4. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B
Front Immunol; 2021; 12():627579. PubMed ID: 33692801
[TBL] [Abstract][Full Text] [Related]
5. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients.
Lage SL; Rocco JM; Laidlaw E; Rupert A; Galindo F; Kellogg A; Kumar P; Poon R; Wortmann GW; Lisco A; Manion M; Sereti I
Front Immunol; 2022; 13():815833. PubMed ID: 35250994
[TBL] [Abstract][Full Text] [Related]
6. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Front Immunol; 2021; 12():663187. PubMed ID: 33841446
[TBL] [Abstract][Full Text] [Related]
7. Is the COVID-19 thrombotic catastrophe complement-connected?
Conway EM; Pryzdial ELG
J Thromb Haemost; 2020 Nov; 18(11):2812-2822. PubMed ID: 32762081
[TBL] [Abstract][Full Text] [Related]
8. Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.
Eriksson O; Hultström M; Persson B; Lipcsey M; Ekdahl KN; Nilsson B; Frithiof R
Thromb Haemost; 2020 Dec; 120(12):1720-1724. PubMed ID: 32871607
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
Front Immunol; 2021; 12():664209. PubMed ID: 34054832
[TBL] [Abstract][Full Text] [Related]
10. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
[TBL] [Abstract][Full Text] [Related]
11. Change in platelet indices in patients with Coronavirus disease-2019 (COVID-19): A reflection of platelet activation and contribution to immunothrombosis?
Mezgebe M; Jacobson BF; Mayne ES; Louw S
Int J Lab Hematol; 2022 Feb; 44(1):e46-e48. PubMed ID: 34519428
[No Abstract] [Full Text] [Related]
12. Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study.
Bruni F; Charitos P; Lampart M; Moser S; Siegemund M; Bingisser R; Osswald S; Bassetti S; Twerenbold R; Trendelenburg M; Rentsch KM; Osthoff M
Front Immunol; 2022; 13():941742. PubMed ID: 36203596
[TBL] [Abstract][Full Text] [Related]
13. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
de Nooijer AH; Grondman I; Janssen NAF; Netea MG; Willems L; van de Veerdonk FL; Giamarellos-Bourboulis EJ; Toonen EJM; Joosten LAB;
J Infect Dis; 2021 Feb; 223(2):214-224. PubMed ID: 33038254
[TBL] [Abstract][Full Text] [Related]
14. Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections.
Huber S; Massri M; Grasse M; Fleischer V; Kellnerová S; Harpf V; Knabl L; Knabl L; Heiner T; Kummann M; Neurauter M; Rambach G; Speth C; Würzner R
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960645
[TBL] [Abstract][Full Text] [Related]
15. Complement(ing) long-COVID thromboinflammation and pathogenesis.
Lee JD; Woodruff TM
Trends Immunol; 2024 Jun; 45(6):397-399. PubMed ID: 38637200
[TBL] [Abstract][Full Text] [Related]
16. Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19.
Ruggeri T; De Wit Y; Schärz N; van Mierlo G; Angelillo-Scherrer A; Brodard J; Schefold JC; Hirzel C; Jongerius I; Zeerleder S
J Innate Immun; 2023; 15(1):850-864. PubMed ID: 37939687
[TBL] [Abstract][Full Text] [Related]
17. Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
Aid M; Busman-Sahay K; Vidal SJ; Maliga Z; Bondoc S; Starke C; Terry M; Jacobson CA; Wrijil L; Ducat S; Brook OR; Miller AD; Porto M; Pellegrini KL; Pino M; Hoang TN; Chandrashekar A; Patel S; Stephenson K; Bosinger SE; Andersen H; Lewis MG; Hecht JL; Sorger PK; Martinot AJ; Estes JD; Barouch DH
Cell; 2020 Nov; 183(5):1354-1366.e13. PubMed ID: 33065030
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM
Front Immunol; 2021; 12():779453. PubMed ID: 34887867
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
[TBL] [Abstract][Full Text] [Related]
20. Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation.
Díaz-García E; García-Tovar S; Alfaro E; Zamarrón E; Mangas A; Galera R; Ruíz-Hernández JJ; Solé-Violán J; Rodríguez-Gallego C; Van-Den-Rym A; Pérez-de-Diego R; Nanwani-Nanwani K; López-Collazo E; García-Rio F; Cubillos-Zapata C
Front Immunol; 2022; 13():847894. PubMed ID: 35173744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
